WO2005120235A3 - Propellant formulations - Google Patents

Propellant formulations Download PDF

Info

Publication number
WO2005120235A3
WO2005120235A3 PCT/US2005/013841 US2005013841W WO2005120235A3 WO 2005120235 A3 WO2005120235 A3 WO 2005120235A3 US 2005013841 W US2005013841 W US 2005013841W WO 2005120235 A3 WO2005120235 A3 WO 2005120235A3
Authority
WO
WIPO (PCT)
Prior art keywords
biological
present
biological analogues
analogues
propellant formulations
Prior art date
Application number
PCT/US2005/013841
Other languages
French (fr)
Other versions
WO2005120235A2 (en
Inventor
David S Alburty
Kelly L Brown
Andrew E Page
Michael F Fischer
Original Assignee
Midwest Res Inst Inc
David S Alburty
Kelly L Brown
Andrew E Page
Michael F Fischer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Midwest Res Inst Inc, David S Alburty, Kelly L Brown, Andrew E Page, Michael F Fischer filed Critical Midwest Res Inst Inc
Publication of WO2005120235A2 publication Critical patent/WO2005120235A2/en
Publication of WO2005120235A3 publication Critical patent/WO2005120235A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A01N25/06—Aerosols
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Abstract

The present invention provides propellant formulations for non-pharmaceutical use in dispersing insoluble particles having biological activity, such as bacterial spores and/or biological analogues, using a dispersion device such as a metered-dose inhaler. It is preferred that the propellant formulations of the present invention are chemically compatible with the biological analogues with which they are to be used, have substantially the same specific gravity as the biological analogues, and have sufficient vapor pressure to prevent agglomeration of the biological analogues. Methods of dispersing said biological analogues in accordance with the present invention are also provided.
PCT/US2005/013841 2004-04-23 2005-04-22 Propellant formulations WO2005120235A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/830,514 2004-04-23
US10/830,514 US20050238632A1 (en) 2004-04-23 2004-04-23 Propellant formulations

Publications (2)

Publication Number Publication Date
WO2005120235A2 WO2005120235A2 (en) 2005-12-22
WO2005120235A3 true WO2005120235A3 (en) 2006-02-02

Family

ID=35136702

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/013841 WO2005120235A2 (en) 2004-04-23 2005-04-22 Propellant formulations

Country Status (2)

Country Link
US (1) US20050238632A1 (en)
WO (1) WO2005120235A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1024189B1 (en) * 2016-10-28 2017-12-05 Yun NV SPRAYER WITH BACTERIAL SPECIES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223244A (en) * 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US20030158459A1 (en) * 1998-06-30 2003-08-21 Tucker Mark D. Enhanced formulations for neutraliztion of chemical, biological and industrial toxants
US20040259234A1 (en) * 2003-06-06 2004-12-23 Northrop Grumman Corporation Detection and analysis of chemical and biological materials

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
EP0376104B2 (en) * 1988-12-27 2003-08-20 Osaka Shipbuilding Co., Ltd. Aerosol composition
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
DK0616525T3 (en) * 1991-12-12 1996-01-08 Glaxo Group Ltd medications
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
US6461591B1 (en) * 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
AU748867B2 (en) * 1998-07-24 2002-06-13 Jagotec Ag Medicinal aerosol formulations
ES2193726T3 (en) * 1998-08-04 2003-11-01 Jago Res Ag MEDICINAL AEROSOL FORMULATIONS.
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US6436367B1 (en) * 1998-12-21 2002-08-20 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6432383B1 (en) * 2000-03-30 2002-08-13 Generex Pharmaceuticals Incorporated Method for administering insulin
US20030068303A1 (en) * 2001-05-11 2003-04-10 Selvig Thomas A. Biologic-chemical fungicide compositions and methods of use
US6498137B1 (en) * 2001-06-27 2002-12-24 Spartan Chemical Company, Inc. Aerosol cleaning composition containing an organic acid and a spore forming microbial composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223244A (en) * 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US20030158459A1 (en) * 1998-06-30 2003-08-21 Tucker Mark D. Enhanced formulations for neutraliztion of chemical, biological and industrial toxants
US20040259234A1 (en) * 2003-06-06 2004-12-23 Northrop Grumman Corporation Detection and analysis of chemical and biological materials

Also Published As

Publication number Publication date
WO2005120235A2 (en) 2005-12-22
US20050238632A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
WO2008138936A3 (en) Atomizer, and filter
WO2008051621A3 (en) Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
WO2007040853A8 (en) Fluid delivery devices, systems and methods
WO2007090822A3 (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
MX2007012228A (en) Device for dosing and dry nebulization.
WO2006028996A3 (en) Emulsan-alginate microspheres and methods of use thereof
WO2004037316A3 (en) Nanoparticle delivery system
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2008061243A3 (en) Respiratory syncytial virus-virus like particle (vlps)
WO2004087153A3 (en) Use of organic compounds for immunopotentiation
TW200731971A (en) Solid preparation
WO2005102431A3 (en) Aerosol delivery apparatus for pressure assisted breathing
WO2006042206A3 (en) Systems and methods for direct restoration of foraminal volume
WO2007019554A3 (en) Polysaccharides for delivery of active agents
TW200612945A (en) Aerosol suspension formulations containing TG 227 ea as propellant
WO2008129548A3 (en) A system for delivering therapeutic agents into living cells and cells nuclei
MY146557A (en) Revaprazan-containing solid dispersion and process for the preparation thereof
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2009025116A1 (en) Cdh3 peptide and medicinal agent comprising the same
IL195935A0 (en) 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
WO2010014827A3 (en) Formulations containing large-size carrier particles for dry powder inhalation aerosols
WO2005065456A3 (en) Active substance combinations having insecticidal properties
WO2007019178A3 (en) Corn protein concentrates
MX2008010806A (en) System for delivering nebulized cyclosporine and methods of treatment.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase